About BioDtech
BioDtech is a company based in Birmingham (United States) founded in 2003 was acquired by Predictive Oncology in July 2020. BioDtech has raised $1.6 million across 3 funding rounds from investors including Predictive Oncology, HHS and Greer Capital Advisors. BioDtech operates in a competitive market with competitors including Abcam, Sino Biological, GenScript, Stem Cell Technologies and Miltenyi Biotec, among others.
- Headquarter Birmingham, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.6 M (USD)
in 3 rounds
-
Latest Funding Round
$1.13 M (USD), Grant
Sep 01, 2014
-
Investors
Predictive Oncology
& 2 more
-
Employee Count
Not available
-
Acquired by
Predictive Oncology
(Jul 06, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BioDtech
BioDtech has successfully raised a total of $1.6M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $1.13 million completed in September 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BioDtech
BioDtech has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Predictive Oncology, HHS and Greer Capital Advisors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
AI-based platform for cancer diagnostics and precision medicine is utilized.
|
Locked | Locked | Locked |
Investor details for BioDtech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioDtech
Investment portfolio details for BioDtech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioDtech
Detailed financials for BioDtech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biodtech Comparisons
Peer comparison for BioDtech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioDtech
BioDtech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Sino Biological, GenScript, Stem Cell Technologies and Miltenyi Biotec, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Developer of cell culture media and ancillary reagents for life science research
|
|
| Locked | Locked | Locked |
Develops tools and products for research and clinical application
|
|
| Locked | Locked | Locked |
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
|
Detailed competitors of BioDtech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biodtech
Complete news archive for BioDtech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioDtech
BioDtech was founded in 2003 and raised its 1st funding round 4 years after it was founded.
BioDtech is headquartered in Birmingham, United States. It is registered at Birmingham, Alabama, United States.
BioDtech is a funded company, having raised a total of $1.6M across 3 funding rounds to date.
BioDtech was founded in 2003 and is based in Birmingham, United States. Products for the bioresearch and bioprocess sectors are developed, focusing on endotoxin detection, neutralization, and removal. Reagents for assay development are provided, along with services for endotoxin detection and removal from aqueous solutions using EndoBind-R technology. A license agreement with the National University of Singapore grants worldwide rights for these products.
BioDtech's top competitors include Abcam, Sino Biological and Meridian Bioscience.
BioDtech has 3 investors. Key investors include Predictive Oncology, HHS, and Greer Capital Advisors.